XML 66 R57.htm IDEA: XBRL DOCUMENT v3.25.3
Notes Receivable (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 27, 2025
USD ($)
Jan. 15, 2025
USD ($)
Sep. 30, 2025
USD ($)
shares
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
item
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Long-Term Notes Receivable                    
Total notes receivable     $ 1,150     $ 1,150   $ 1,150   $ 6,100
Aggregate principal amount               1,150 $ 500  
Amount repaid               5,903    
Capital gains           803   803    
Senior secured promissory notes                    
Long-Term Notes Receivable                    
Total notes receivable                   1,000
Promissory note                    
Long-Term Notes Receivable                    
Total notes receivable     $ 1,150     $ 1,150   $ 1,150    
Secured convertible promissory notes                    
Long-Term Notes Receivable                    
Total notes receivable                   $ 5,100
Mellitus | Senior secured promissory notes                    
Long-Term Notes Receivable                    
Aggregate principal amount         $ 1,000          
Number of notes receivable | item         2          
Interest rate (as a percent)         5.00%          
Impairment of principal balance             $ 1,000      
Impairment of accrued interest             $ 135      
Monarch | Secured convertible promissory notes                    
Long-Term Notes Receivable                    
Aggregate principal amount       $ 5,000            
Interest rate (as a percent)       10.00%            
Maximum amount of available funding       $ 5,000            
Amount repaid   $ 3,500                
Monarch | New Note                    
Long-Term Notes Receivable                    
Total notes receivable   $ 1,500                
Interest rate (as a percent)   15.00%                
Number of Class B units upon conversion | shares     76,986              
Consideration     $ 2,303              
Number of B units sold | shares     76,986              
Capital gains     $ 803              
CardioVanta | Licensor | Promissory note                    
Long-Term Notes Receivable                    
Aggregate principal amount $ 1,150                  
Maximum amount of available funding 4,600                  
Principal amount elected not to lend $ 3,450                  
Interest rate (as a percent) 12.00%